Voyager Therapeutics Inc (NASDAQ: VYGR) stock closed at $10.54 on 4/1/24 after a major increase of 13.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 212% of normal. The stock has been weak relative to the market over the last nine months but has risen 12.1% during the last week.
Current PriceTarget Research Rating
VYGR’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to be Value Creation neutral.
Voyager Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Voyager Therapeutics has a slightly negative Power Rating of 38 and a very low Appreciation Score of 3, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment